
StemCell
7096.TStemCell Institute Inc. Price (7096.T)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
10,246,554
(390374.9923)%Income Statement Summary
Revenue | |
Cost of Revenue | |
Gross Profit | |
Operating Expenses | |
Operating Income | |
Other Expenses | |
Net Income |


Income Statement
StemCell Institute Inc.Currency: JPY
YEAR | 2019 | 2020 | 2021 | 2022 | 2023 | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||
Revenue |
1,676,000,000.00
+0% |
1,409,515,000.00
-16% |
1,781,943,000.00
+26% |
2,091,293,000.00
+17% |
2,481,193,000.00
+19% |
||||||||||||||
Cost of Revenue | |||||||||||||||||||
Cost of Revenue | 543,000,000.00 | 485,307,000.00 | 670,686,000.00 | 755,450,000.00 | 905,311,000.00 | ||||||||||||||
Gross Profit | |||||||||||||||||||
Gross Profit |
1,133,000,000.00
+0% |
924,208,000.00
-18% |
1,111,257,000.00
+20% |
1,335,843,000.00
+20% |
1,575,882,000.00
+18% |
||||||||||||||
Gross Profit Ratio | (0.68%) | (0.66%) | (0.62%) | (0.64%) | (0.64%) | ||||||||||||||
Operating Expenses | |||||||||||||||||||
Research and Development | 3,000,000.00 | 8,000,000.00 | 9,000,000.00 | 9,000,000.00 | 11,424,000.00 | ||||||||||||||
General and Administrative | 0.00 | 664,000,000.00 | 700,000,000.00 | 832,000,000.00 | 947,000,000.00 | ||||||||||||||
Selling, General & Admin... | 750,000,000.00 | 830,000,000.00 | 875,000,000.00 | 1,026,000,000.00 | 1,131,523,000.00 | ||||||||||||||
Selling & Marketing Exp... | 0.00 | 166,000,000.00 | 175,000,000.00 | 194,000,000.00 | 196,000,000.00 | ||||||||||||||
Depreciation and Amortiz... | -383,000,000.00 | 32,781,000.00 | 96,913,000.00 | 104,932,000.00 | 120,594,000.00 | ||||||||||||||
Other Expenses | 0.00 | 5,430,000.00 | -9,289,000.00 | 935,000.00 | 9,000,000.00 | ||||||||||||||
Total Operating Expenses | 751,000,000.00 | 837,327,000.00 | 884,305,000.00 | 1,038,282,000.00 | 1,162,122,000.00 | ||||||||||||||
Cost and Exponses | 1,294,000,000.00 | 1,322,634,000.00 | 1,554,991,000.00 | 1,793,732,000.00 | 2,067,433,000.00 | ||||||||||||||
Operating Income | |||||||||||||||||||
Operating Income |
383,000,000.00
+0% |
86,879,000.00
-77% |
226,952,000.00
+161% |
297,560,000.00
+31% |
413,759,000.00
+39% |
||||||||||||||
Operating Income Ratio | (0.23%) | (0.06%) | (0.13%) | (0.14%) | (0.17%) | ||||||||||||||
Other Income and Exp... | |||||||||||||||||||
Interest Income | 94,000.00 | 97,000.00 | 1,138,000.00 | 1,868,000.00 | 3,527,000.00 | ||||||||||||||
Interest Expenses | 0.00 | 0.00 | 27,000.00 | 0.00 | 0.00 | ||||||||||||||
Total Other Income/Exp... | 0.00 | 4,567,000.00 | -14,398,000.00 | -18,603,000.00 | 27,568,000.00 | ||||||||||||||
EBITDA | |||||||||||||||||||
EBITDA | -1,000,000.00 | 119,661,000.00 | 309,468,000.00 | 383,889,000.00 | 534,000,000.00 | ||||||||||||||
EBITDA ratio | (0.00%) | (0.09%) | (0.17%) | (0.20%) | (0.22%) | ||||||||||||||
Income Before Tax | |||||||||||||||||||
Income Before Tax | 382,000,000.00 | 91,446,000.00 | 212,554,000.00 | 278,957,000.00 | 441,327,000.00 | ||||||||||||||
Income Before Tax Ratio | (0.23%) | (0.06%) | (0.12%) | (0.13%) | (0.18%) | ||||||||||||||
Income Tax Expense | |||||||||||||||||||
Income Tax Expense | 105,000,000.00 | 29,074,000.00 | 78,827,000.00 | 80,924,000.00 | 130,346,000.00 | ||||||||||||||
Net Income | |||||||||||||||||||
Net Income | 277,000,000.00
+0% |
62,371,000.00
-77% |
133,726,000.00
+114% |
198,032,000.00
+48% |
310,981,000.00
+57% |
||||||||||||||
Net Income Ratio | (0.17%) | (0.04%) | (0.08%) | (0.09%) | (0.13%) | ||||||||||||||
Earning Per Share | |||||||||||||||||||
Basic EPS | 28.46 | 6.41 | 13.20 | 19.33 | 30.25 | ||||||||||||||
Diluted EPS | 27.03 | 6.41 | 13.20 | 19.33 | 30.25 | ||||||||||||||
Share Outstanding | |||||||||||||||||||
Basic Share Outstanding | 9,734,200.00 | 9,734,200.00 | 10,128,678.00 | 10,246,558.00 | 10,246,554.00 | ||||||||||||||
Diluted Share Outstanding | 10,246,600.00 | 9,734,200.00 | 10,128,678.00 | 10,246,558.00 | 10,246,554.00 |